Posted by Michael Wonder on 07 Aug 2017
Blood cancer drug accepted for NHS use in Scotland
7 August 2017 - A drug which can increase survival rates for blood cell cancer sufferers has been accepted for routine use by NHS Scotland.
The Scottish Medicines Consortium approved carfilzomib (Kyprolis) to treat multiple myeloma - a complex blood cell cancer.
The drug can increase overall survival compared to other current treatments and has fewer negative side effects.
